Category Archives: Drugs

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Elderly Alcoholism Growing Problem For America

Leave a comment

While the elderly within America are growing in number, so is their problem of alcoholism.

Medical literature has been cited to say that 10 to 15 percent of persons 65 years of age and older have a drinking problem.

“We tend to think that alcoholism is a young to middle age problem,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center. “That’s simply not the case. In fact, it could be said that the elderly population present greater risk factors than their younger counterparts. For example, when one becomes older, he /she can become isolated due to the death within his/her circle of friends. In addition, after retiring, an individual can become depressed, leading to more isolation. It’s important to look out for the warning signs of alcoholism among the elderly population and to help them remain actively engaged in life. We have to remember that alcoholism is not just a problem plaguing the youth of America – it’s a problem plaguing America as a whole.”

The dangers of alcohol consumption in the elderly can be far greater than any other age group. Medications that are commonly prescribed for the elderly often cause adverse reactions when combined with alcohol. In addition, alcohol can depresses the immune system, exacerbating the effects of otherwise treatable, common illnesses.

If you have an elderly or aged parent or relative who you suspect may have a problem with alcohol, Mountainside Drug Rehab and Alcohol Treatment Center can provide specialized intervention services that will assist you in approaching your loved one in a concerned, loving manner that will help them begin their journey to recovery.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Sounding The Alarm On Drug Abuse

Leave a comment

In recent times, a startling number of Hollywood and pop star elite have become slaves to the effects of drug and/or alcohol abuse. Many of these individuals’ lives and the lives of their families have been drastically impacted either through their imprisonment, or worse, their death.

“America and the entire world tends to idolize the rich and famous,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “We see the lights, the big city, the seemingly-exciting lives they lead. But, many fail to see that the perks of a Hollywood and pop star lifestyle also have challenges, many of which can lead to drug or alcohol abuse. It isn’t until a tragedy, such as death by overdose, happens that we are shocked back into reality and realize the magnitude of the many issues faced by those who are viewed as enjoying fame and fortune. The enemy for them can be drugs and alcohol.”

In a six-year period, the Centers For Disease Control (CDC) reported that unintentional drug overdose deaths more than doubled within the United States. Additionally, unintentional drug overdose became the second leading cause of unintentional injury, slightly behind car accidents. Most of the accidental overdoses were attributed not to illegal street drugs such as heroin or cocaine, but were found to be mostly associated with prescription narcotics.

Initially, the signs of drug use and abuse can be difficult to discern. However, as time goes on and the use and abuse gets worse, the signs are easily detected. If you suspect that your loved one is experimenting with drugs, you can help them by utilizing professional intervention services, which are offered by Mountainside Drug Rehab and Alcohol Treatment Center.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential inquiry at 800-762-5433.

Via EPR Network
More Healthcare press releases

Biotech, Disorders, Doctors, Drugs, Genetics, Health 2.0, Healthcare, Healthcare Professionals, Hospitals, Pharmaceuticals

Great Ormond Street Hospital Patients Take Part In Duchenne Muscular Dystrophy Clinical Trial

Leave a comment

Great Ormond Street Hospital has announced that a team led by scientists at its research partner, UCL Institute of Child Health (ICH), funded by the Medical Research Council (MRC) and AVI BioPharma, have made an important breakthrough in the development of a treatment for Duchenne Muscular Dystrophy (DMD).

Together with the MDEX Consortium, chaired by the ICH’s Professor Francesco Muntoni, the group showed that a gene based drug treatment was effective in restoring the dystrophin protein, missing in sufferers of DMD in seven out of 19 trial participants.

The results of the clinical trial will be published in The Lancet, a world leading general medical journal.

DMD is a devastating and life limiting condition, affecting one in 3,500 male births in the general population, with around 100 cases diagnosed in the UK each year.

Three of the participants in the higher dose cohort showed dystrophin levels exceeding 18 per cent of those found in normal muscle.

Thirteen per cent of boys with DMD could be treated with this specific ‘antisense’ gene therapy, the largest group by a single antisense. Overall, scientists say this approach could work for at least 70 per cent of DMD sufferers.

DMD causes progressive muscle weakness due to the breakdown and loss of muscle cells. Patients lack a single important protein in their muscle fibres called dystrophin. By ages eight to 12 years boys become unable to walk, and by their late teens or early twenties the condition can become severe enough to limit life expectancy.

In this clinical trial of 19 patients, study participants aged five to 15 at Great Ormond Street Hospital and the Royal Victoria Infirmary, Newcastle, were given weekly doses of the drug, AVI-4658. The drug had already been tested for safety and efficacy by the MDEX Consortium and AVI Biopharma in an earlier phase of the study.

Francesco Muntoni, professor of paediatric neurology at the ICH, said: “These are very exciting results that prove the case for an even more detailed look at this genetic therapy. I’ve worked with patients with DMD for many years and this is the first time we can say with confidence that we’ve made a significant breakthrough towards finding a targeted treatment.

“Importantly, the study drug was extremely well tolerated, with no appreciable side effects detected during the study period in any of the boys. If our strategy shows continued success, this therapy could substantially reduce muscle damage in affected boys with DMD, improve the quality of life for DMD patients, their mobility and the way their condition is managed as they get older.”

Professor Max Parmar, director of the MRC Clinical Trials Unit, said: “A large proportion of new drugs do not make it past the phase II stage of testing reached here, so there is real excitement that this treatment could work.

Brothers Jack, 11, and Tom, 8 were enrolled on the trial. Both have DMD with a deletion from 45-50. Their mum, Claire, said: “Jack and Tom were placed on a DMD genetic registry, co-ordinated by Action Duchenne, which is how we were approached about the clinical trial at Great Ormond Street Hospital.

“The boys were on the trial for 12 weeks between 2009 and 2010. Our whole family noticed a marked difference in both of their quality of life and mobility over that period. We feel that it helped prolong Jack’s mobility and that Tom has been considerably less fatigued.”

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

New Deadly Designer Drugs Emerge In Russia

Leave a comment

Designer drugs aren’t just a problem facing America. In fact, they’re fast becoming an international epidemic.

The newest designer drug to affect Russia’s youth is simply called krokodil . Bearing the name of one of the deadliest reptiles, it shouldn’t come as any surprise that most individuals who become addicted to the drug, die or, at best, suffer massive, irreparable brain damage.

“While this newest designer drug has yet to hit America , it’s important to take note of the countries that it is affecting,” begins a spokesperson for Mountainside Drug Rehab. “We have to understand the enemy because, as much as we don’t want to believe that America will remain unaffected, that’s simply not true. And, this is one of the most deadly designer drugs we’ve seen.”

The active component in krokodil is a commonly available narcotic called codeine. To the codeine is added various lethal ingredients, sometimes even paint thinners. It’s then injected, producing a high that is similar to heroine and lasts, generally, just about an hour. Youth prefer krokodil to heroine as it’s cheaper and easier to obtain. Many who become addicted die within two to three years.

While krokodil hasn’t emerged as a widely used substance in America, there are plenty of other designer drugs on the market that young people are using. If you know or suspect that your loved one may have a problem with designer drugs or any drug abuse and experimentation, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Rise in drug rehab admissions call for holistic drug rehab

Leave a comment

A report recently released by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) revealed an 8 percent increase in opiate rehab admissions over the past decade. Alcohol and marijuana also saw an increase in rehab admissions – alcohol, at 42 percent, with the second being opiates, including prescription pain killers, at 21 percent.“We are interested solely in getting people into recovery, not just into rehab,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center. “This report doesn’t address how many individuals entered rehab a second or third time due to relapse; unfortunately, relapse is very commonplace. Mountainside is proud that individuals leaving its program have above-average, long-term sobriety success rates. Our program utilizes a holistic approach to treating individuals as opposed to simply treating the addiction. Our drug rehab is truly individualized for each person and that is one of the reasons our clients have such great success with staying sober.”

If you know or suspect that your loved one may have a problem with alcohol addictionor any other type of addiction, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.
The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.
If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential inquiry at 800-762-5433.

Via EPR Network
More Healthcare press releases

Drugs, Healthcare, Online, Pharmaceuticals

Recently Launched Pharmacy Xpressdelivery.Com Offers Fair Deals On Popular Drugs

Leave a comment

New online pharmacy xpressdelivery.com has been launched, offering its services to international customers. This is the first online drugstore to offer cheap generic Viagra online and other impotence medications at a fair price.

Xpressdelivery.com was launched with an understanding of the market lacking a pharmacy that would be truly committed to providing high level of service without charging too much money. This pharmacy was started as a place where it would be possible to buy viagra online, as well as purchase some other highly demanded medications that can be very expensive to buy without a prescription. Because of the company’s close cooperation with the largest manufacturer of cheap generic drugs (generic Viagra being one of them), xpressdelivery.com can offer affordable prices and more options for the customer to save money and leave satisfied. The pharmacy is ready to offer convenient shopping options to its customers, and new ones are introduced every day.

Xpressdelivery.com is planning to become truly international and popular with customers looking to save their money without the quality of their generic Viagra affected. Presently, it’s looking into the opportunity to cooperate with another large manufacturer, that way being able to offer a wider choice of medications at even more attractive prices. Due to years of experience its members of staff have, as well as constant attention to perfecting the services offered to new and regular customers, this pharmacy has already found its niche in the market and will keep working on bringing more advantages to people interested in saving money while shopping for their drugs online.

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Driving While ‘Buzzed’ Is Still Significant Risk For Life-Threatening Accidents

Leave a comment

A recently published report indicates that driving while even slightly buzzed causes increased traffic accidents.

The journal, Addiction , published a study from the University of California San Diego which shows that individuals who are buzzed while driving are more likely to speed as well as not use their seatbelts properly. In addition, researchers found that accidents involving alcohol, even at a scant, detectable level, are 36.6 percent more severe than accidents that don’t have alcohol as a contributing factor.

“Many people think, ‘I’ve only had one drink; I’ll be fine to drive’, but this research clearly shows that this is not the case,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “Understanding the effects of alcohol on the brain, we’ve always been advocates for not driving after consuming what is perceived as a small amount of alcohol. Functionality of the brain is impaired, even with supposed insignificant amounts of alcohol. It’s important to always designate a non-drinking driver when consuming even just one drink. “

This particular study bolsters the position of many who advocate lowering the legal limit of intoxication in an effort to save more lives.

If you know or suspect that your loved one may have a problem with alcohol addiction or any other type of addiction, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Waters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Holistic Drug Rehab Effective For Combatting Increased Benzodiazepine Abuse

Leave a comment

The Substance Abuse Mental Health Services Administration (SAMHSA) recently published a study that indicates benzodiazepine usage has tripled over the past decade.

Benzodiazepines are a class of drugs which are used to treat seizures, anxiety and insomnia. They were created back in the 1950’s as an alternative to barbiturate use within the mental health field. While opiates still remained the number one abused controlled substance in this study, benzodiazepines ranked number two.

“All FDA approved medications have their place when used properly,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “The issue is when those substances fall into the wrong hands. And, since there are more individuals being prescribed these types of drugs, the chances of abuse by a friend or relative are increased. Fortunately, holistic drug rehab is effective in overcoming these types of addictions. Mountainside’s entire team of professional social workers and counselors all have extensive experience in the field of addiction. Our drug rehab program is second to none.”

If you know or suspect that your friend or loved one is abusing benzodiazepines, or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers, as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Waters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

Biotech, Business of Medicine, Drugs, Health 2.0, Healthcare, Healthcare Information, Healthcare Services, Healthcare Software, Healthcare Solutions, Online, Pharmaceuticals

Enabling microRNA Discoveries – 250th Peer-Reviewed Publication Made Possible By µparaflo Custom Microarray Technology

Leave a comment

LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the company’s microarray service for analyzing miRNA expression profiles. These studies, by leading researchers in the field, represent significant steps toward realizing these small regulatory RNA’s potential as biomarkers and therapeutic targets.

MiRNAs have proven to be an extremely important part of the gene expression regulation mechanism of a wide variety of cellular processes. This is evident in the amount of relevant findings by LC Sciences’ customers being translated into published reports and the diverse range of study areas that these publications encompass: cancer research, neuroscience, cardiovascular research, reproductive biology, plant science, microbiology, immunology and stem cell research. LC Sciences’ miRNA profiling service, powered by its µParaflo® custom microarray technology, provides quick, reliable, fully analyzed datasets enabling researchers to immediately move forward with groundbreaking research.

The miRNA field is still nascent, and it is advancing rapidly. The race to discovery has produced a continuous stream of new miRNA sequences as well as routine revisions of inaccurate or incomplete sequences. This fluidity has caused many microarrays with static content to fall away and has fueled reports of the wholesale replacement of microarrays by new methods such as RNA-Seq. But the nimble, customizable format of the µParaflo® array has given it staying power, not only by enabling it to keep current with all known miRNAs, but also by making use of data generated by RNA-Seq. These custom arrays have benefited from RNA-sequencing generating novel content that other arrays are unable to capture and take advantage of.

The 250th study, entitled “Wolbachia uses host microRNAs to manipulate host gene expression and facilitate colonization of the dengue vector Aedes aegypti.” appeared in the May 31st issue of PNAS and was one of a group of articles published recently by LC Sciences’ customers describing microarray expression analysis of miRNAs recently discovered through RNA Sequencing.

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Bath Salt Abuse Becoming International Problem

Leave a comment

The most recent substance abused and labeled a designer drug is fast becoming an international epidemic.

Bath salts, a potentially deadly combination of various chemicals such as mephedrone and MDPV, are highly addictive and extremely dangerous, producing hallucinations and physical manifestations that can be fatal.

“What’s remarkable about this substance is that, on the package, it is actually labeled ‘not for human consumption’,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “It’s terrifying to think that experimentation happens with substances that aren’t even to be ingested into the human body. And, unfortunately America is not the only country to be grossly affected by this epidemic. Countries such as England are also experiencing marked increase in the improper use of bath salts as well as the detrimental effects that follow bath salt abuse.”

Bath salts are particularly appealing to teens and young adults for a variety of reasons, mainly because they are easy and inexpensive to obtain. Producing side effects such as hallucinations and heart palpitations, the effects of the improper use of bath salts have been cited as the cause of death in several autopsies performed globally.

If you know or suspect that your teen or young adult is abusing bath salts or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases

Diseases, Drugs, Healthcare, Healthcare Information, Healthcare Professionals, Medicine, Society

A Dream Team for HIV Cure Research

Leave a comment

This Sunday will mark the 30th anniversary of the first reports of AIDS in the United States. There is still a long road ahead toward eradicating HIV, but a “dream team for HIV reservoirs cure” has been created since 2003 with this objective.

While the HIV pandemic is still growing, with more than 7,100 daily new cases of infection, there is evidence that antiretroviral therapy costs could treble over the next 20 years.

Today there are more than 30 drugs approved to treat HIV, and while they cannot cure it, they can keep the virus suppressed to undetectable levels in blood. But HIV persists dormant in some “reservoir” and each time antiretroviral therapy is stopped, the infection rekindles. Lifelong therapy is therefore mandatory but brings problems of compliance, resistance, toxicity and cost.

These reservoirs were first described in 1997 and 5 years later Alain Lafeuillade, a French Doctor involved in HIV research, considered that it would be the challenge of the 21st Century. He consequently founded a working group uniting researchers from all over the world that first met in December 2003. This first “HIV Reservoirs, Persistence and Eradication Strategies Workshop” welcomed around 130 scientists actively involved in the field. “At that time we were seen as utopists, Doctor Lafeuillade said, and quite ignored by funding agencies and pharmaceutical companies”.

But minds greatly changed in the following years and in 2009, when the “dream team” met for the 4th time, the workshop was officially supported by the NIH (National Institutes of Health) and the ANRS (French Agency for AIDS Research). In between 2 workshops, the group of scientists are in touch via a specialized website portal they also have created.

“At the end of this year we will reconvene, Doctor Lafeuillade added, and be more than 200 scientists working on HIV cure”. The program of this 5th workshop goes from in vitro models of HIV persistence to HIV eradication clinical trials. “Participants will be able to define a clear road map for HIV cure research with a precise agenda”, Doctor Lafeuillade emphasized.

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Bath Salts Pose Legitimate Danger For Teens, Young Adults

Leave a comment

It may be difficult to believe that something with such an innocuous name can be so dangerous, even deadly.

A new designer drug marketed as “bath salts” has nothing to do with a relaxing time bathing. In fact, many are using the product with no thought of relaxing at all.

“Bath salts are being legally sold and are being used by more and more young people to get high,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “They can be found at many convenience stores or smoke shops, and they contain stimulants such as mephedrone and MDPV. Individuals generally snort them to get high, but they can also be smoked or injected. Some states have banned the sale of bath salts and Mountainside is hoping to help push a nationwide ban on the substance. If we don’t address this problem immediately, there will be a whole new drug epidemic plaguing America and, with that, comes tragic deaths.”

Bath salts are among the growing group of the so-called designer drugs that produce a high similar to that of a methamphetamine or cocaine, but with the addition of hallucinogenic side effects. Sold under a variety of different names, the use of bath salts has been linked to suicide, hallucinogenic rages, and even speculation of murder.

If you know or suspect that your teen or young adult is abusing bath salts or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Bath Salts Abuse Tops Newest Designer Drug Trend

Leave a comment

The use of bath salts among teens and young adults is fast becoming the drug of choice to obtain a “legal high” because of their relative low cost as well as their ease of acquisition.

“Designer drugs are simply legal substances that have been modified to produce a high,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “The concept of designer drugs isn’t new; in fact, it has been around for decades. Individuals discovered that they could obtain a high from ordinary chemicals such as paint thinners, glue and aerosol cans. The effects of the substances being manipulated are becoming increasingly dangerous compared to their predecessors. And, the abuse is growing at an alarming rate. Unless lawmakers enact laws banning bath salts, we’re going to have a new type of drug epidemic on our hands.”

Bath salts are commonly smoked, snorted and injected. Their effects have been compared to a hallucinogenic cocaine, with users experiencing much of the same devastating and dangerous side effects such as convulsions, high blood pressure, heart attacks and even death.

If you know or suspect that your teen or young adult is abusing bath salts or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Waters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

Biotech, Business of Medicine, Diseases, Drugs, Healthcare, Healthcare Information, Healthcare Professionals, Healthcare Solutions, Medicine, Online, Pharmaceuticals, Society

New Report on Fighting Chronic Disease Examines the Importance of Non-Communicable Diseases in Global Health Care

Leave a comment

In the first of a series of new reports, a coalition of pharmaceutical industry trade organizations outlines the serious burden that chronic diseases place on patients and global health care systems.“Fighting Chronic Disease: Importance of Non-communicable Diseases” is the first of four reports that look at this growing issue for patients and health care systems around the world.

The report was compiled by the European Federation of the Pharmaceutical Industries and Associations, the International Federation of Pharmaceutical Manufacturers & Associations, the Japan Pharmaceutical Manufacturers Association, and the Pharmaceutical Researchers and Manufacturers Association. Together, these organizations highlight the powerful role that public-private partnerships can play in mitigating the burden of chronic disease. Non-communicable diseases like stroke, heart disease, diabetes, and cancers can often strain global health care resources, and targeting the main risk factors of these conditions can significantly reduce the burden of these diseases worldwide.

Most NCDs are preventable because they are caused by modifiable risk factors, which include poor diet, lack of physical activity and tobacco use. Every year, more than 5 million people die because of direct tobacco use and 2.8 million die from being overweight or obese. High cholesterol accounts for 2.6 million deaths and 7.5 million die because of elevated blood pressure. Individually, chronic disease lowers quality of life for those affected, causes premature deaths and negatively impacts the economic solvency of families, communities and nations. Interventions that focus on better diet, increased physical activity and access to vaccines have been proven to decrease the incidence of chronic disease and improve quality of life.

The pharmaceutical industry has long recognized the economic and social burden of non-communicable diseases (NCDs) and has been working with governments, health care providers, patients groups and other stakeholders as an active solution partner in lessening this burden. The industry promotes and supports health prevention and promotion strategies and patient-centered approaches to managing chronic conditions and their risk factors. At the same time the global biopharmaceutical industry leads the search for new cures and the research and development of new medicines to treat or prevent non-communicable diseases. There are currently thousands of medicines either in clinical trials or awaiting approval to treat NCDs. The great challenge in preventing and controlling NCDs on a global scale is finding patient-centered solutions that reduce the burden on global health care services by promoting individual healthy lifestyles.

The R&D-based pharmaceutical industry works to improve the health and quality of life of all patients, and is committed to continuing partnerships that tackle these complex issues including extensive investment in R&D programs dedicated to the development of new NCD preventative and treatment products. Both prevention and treatment play an important role in addressing the problem of non-communicable diseases.

The full report is available at
http://globalhealthprogress.org/mediacenter/index.php/new-report-examines…

Via EPR Network
More Healthcare press releases

Alternative medicine, Biotech, Business of Medicine, Clinics, Consultations, Doctors, Drugs, Genetics, Gynecology, Health 2.0, Health Reform, Healthcare, Healthcare Information, Healthcare Professionals, Healthcare Services, Medicine, Online, Society

Will the Catholic Church & the U.S. Courts Embrace Advanced Cell Technologies “Embryo-Safe” Technique Using Embryonic Stem Cells?

Leave a comment

Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.
• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Via EPR Network
More Healthcare press releases

Biotech, Business of Medicine, Diseases, Drugs, Healthcare, Healthcare Information, Healthcare Professionals, Healthcare Solutions, Medicine, Online, Pharmaceuticals, Society

Global Health Progress Releases Non-Communicable Diseases Partnerships and Programs List

Leave a comment

Global Health Progress compiled a list of non-communicable disease treatment programs from around the world, highlighting partnerships to address cancer treatment, diabetes care, epilepsy programs and more. The programs, sponsored by leading companies like Astra Zeneca, Abbott, Novo Nordisk, and Bayer Healthcare, aim to increase awareness of non-communicable diseases in the developing world.

“Our goal in creating this list is to bring awareness to these companies who work so hard at fighting diseases in developing countries,” explains Mark Grayson, Vice President of Communications and Public Affairs at PhRMA and key developer in the Global Health Progress initiative. “Non-communicable diseases are the leading killer in many of these countries, and without the help of these programs they would continue to increase.”

Global Health Progress works with partner groups to encourage and sustain funding for the research and development of healthcare in developing nations. Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

Read the full list of non-communicable disease treatment programs here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/NCD-Health-Partnerships-and-Programs_Worldwide-05-02-11.pdf.

Via EPR Network
More Healthcare press releases

Alternative medicine, Biotech, Business of Medicine, Clinics, Consultations, Doctors, Drugs, Genetics, Gynecology, Health 2.0, Health Reform, Healthcare, Healthcare Information, Healthcare Professionals, Healthcare Services, Medicine, Online, Society

Side by side comparison of Advanced Cell Technology & Geron Corporation

Leave a comment

Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements: http://www.sec.gov/Archives/edgar/data/11...

Via EPR Network
More Healthcare press releases

Addictions, Clinics, Diagnostics, Drugs, Healthcare, Healthcare Information, Healthcare Services, Medicine, Rehab, Society, Therapies

Underage Drinking Continues To Plague America

Leave a comment

It’s no secret that many of America’s youth are looking for the quickest fix or high. Often times, they turn to a readily available substance found in many Americans’ homes: alcohol.

Statistics show that by age 18, 70% of teens have had one drink. While it’s true that, when teens do drink, they drink less often than adults; however, when drinking they tend to drink more than adults: approximately 5 drinks on a single occasion.

In addition, research indicates that 40% of adults who started drinking before age 15 say that they have the signs of alcohol dependence, four times higher than for adults who delayed drinking until after 21 years old.

“Underage drinking is a continuing and growing problem in America and is one that is hard fought on many fronts,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “Programs such as DARE and other school-based education programs go a long way in getting the message out about the dangers of underage drinking. With continued effort, we believe that we can decrease the underage drinking statistics and give renewed hope for the future of America.”

Underage drinking is a major contributor to deaths among those under 21 years old. 5,000 people under 21 die as a result of underage drinking annually – approximately 2,000 from motor vehicle crashes, 1,600 from homicides, 300 from suicides and hundreds more from other injuries.

If you know or suspect that your teen or minor has a problem with alcohol, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases

Biotech, Business of Medicine, Diseases, Drugs, Healthcare, Healthcare Information, Healthcare Professionals, Healthcare Solutions, Medicine, Online, Pharmaceuticals, Society

From Universal HIV Testing to HIV Cure

Leave a comment

People involved in the fight against HIV/AIDS will gather in Marseille, France, May 23-25, 2012 for an international AIDS Conference under the theme: ‘From Universal HIV Testing to HIV Cure’.

The ISHEID (International Symposium on HIV & Emerging Infectious Diseases) is a major scientific event attracting doctors, biologists, researchers, patients’ representatives and policy makers from all around the world. Its next edition, to be held just more than one year ahead, will focus on recent developments against this pandemic.

Despite major advances in antiretroviral therapy, HIV still infects daily 2,000 new individuals and kills 2 millions each year. Current treatments are life-long with problems of compliance, resistance, toxicity, access, and cost.

‘There are advances both in the area of prevention, testing and potential cure’ told Alain Lafeuillade, a French Doctor involved in the organization of the conference. ‘Our driving force is to draw to the conference the best experts in the world for each program theme’. Antiretroviral treatment as prevention (or pre-exposure prophylaxis) will be debated with the pros and cons. Human rights and access to HIV care will be the focus of en entire session. Current issues in antiretroviral therapy management will be discussed during 2 sessions. Finally, the best American experts in the field of HIV reservoirs and eradication research will present their latest discoveries in the search for a cure.

The international Steering Committee will actively build a program the most exciting possible in the forthcoming months. Meanwhile, interviews of renowned experts are regularly published on the meeting website: http://www.isheid.com/en/committees/interview.html

Via EPR Network
More Healthcare press releases

Alternative medicine, Biotech, Business of Medicine, Clinics, Consultations, Doctors, Drugs, Genetics, Gynecology, Health 2.0, Health Reform, Healthcare, Healthcare Information, Healthcare Professionals, Healthcare Services, Medicine, Online, Society

New Website Dedicated To Stem Cell Investors

Leave a comment

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Via EPR Network
More Healthcare press releases